Illinois-based Abbott Laboratories (ABT) is a diversified healthcare company that develops and manufactures medical devices, ...

Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.

Abbott (ABT) closed the most recent trading day at $85.68, moving -1.14% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.02%. At the same time, the ...

Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to ...

Earlier this week, the American Cancer Society updated its colorectal cancer screening guidelines, reaffirming Abbott’s Cologuard and Cologuard Plus as preferred noninvasive options for average-risk ...

Abbott said that Ultreon 3.0 is the first optical coherence tomography (OCT) system in both the US and Europe that combines ...

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bulls’ thesis on ABT.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.